Search Results

Filter
  • 1-10 of  3,005 results for ""CHRONIC hepatitis B""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.

  • Authors : Feng Z; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.; Fu J

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism

  • Source: Hepatology international [Hepatol Int] 2024 Aug; Vol. 18 (4), pp. 1122-1134. Date of Electronic Publication: 2024 Jun 03.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4.

  • Authors : He T; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200040, China.; Chen B

Subjects: Telbivudine*/Telbivudine*/Telbivudine*/therapeutic use ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/blood

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jul; Vol. 80 (7), pp. 1029-1038. Date of Electronic Publication: 2024 Mar 19.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

The hepatic steatosis, steatohepatitis and metabolic dysfunction: distinct roles in hepatocellular carcinoma occurrence in chronic hepatitis B patients.

  • Authors : Hu X; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China.; Wen Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/complications ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/etiology

  • Source: Hepatology international [Hepatol Int] 2024 Aug; Vol. 18 (4), pp. 1338-1339. Date of Electronic Publication: 2024 Jun 27.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B.

  • Authors : Zhang M; Department of Liver Diseases, National Clinical Research Center for Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.; Li J

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis B, Chronic*; Adolescent

  • Source: Hepatology international [Hepatol Int] 2024 Apr; Vol. 18 (2), pp. 435-448. Date of Electronic Publication: 2024 Feb 20.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma.

  • Authors : Ayada I; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. .; Li J

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/etiology

  • Source: Hepatology international [Hepatol Int] 2024 Jun; Vol. 18 (3), pp. 1053-1055. Date of Electronic Publication: 2024 Mar 07.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.

  • Authors : Wang Y; Department of Infection, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.; Sun X

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/chemically induced; Humans

  • Source: Hepatology international [Hepatol Int] 2024 Apr; Vol. 18 (2), pp. 702-703. Date of Electronic Publication: 2024 Mar 02.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.

  • Authors : Park JW; Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea.; Yoo JJ

Subjects: Alanine*/Alanine*/Alanine*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects

  • Source: Hepatology international [Hepatol Int] 2024 Apr; Vol. 18 (2), pp. 700-701. Date of Electronic Publication: 2024 Feb 29.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?

  • Authors : Wang FS; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China. .; Li J

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B*/Hepatitis B*/Hepatitis B*/drug therapy; Child

  • Source: Hepatology international [Hepatol Int] 2024 Feb; Vol. 18 (1), pp. 296-298. Date of Electronic Publication: 2023 Oct 31.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis.

  • Authors : Tong K; Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Chen M

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy; Humans

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Mar; Vol. 80 (3), pp. 335-354. Date of Electronic Publication: 2024 Jan 10.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B.

  • Authors : Faure-Dupuy S; Institut Cochin, Université de Paris, Inserm, U1016, CNRS, UMR 8104, 75014, Paris, France.; Baumert TF

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B*; Humans

  • Source: Hepatology international [Hepatol Int] 2023 Oct; Vol. 17 (5), pp. 1075-1078. Date of Electronic Publication: 2023 Jun 27.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  3,005 results for ""CHRONIC hepatitis B""